1221819-62-0 Usage
General Description
4-(3-oxetanyl)benzenamine, also known as 3-(4-aminophenyl)oxetane, is a chemical compound with the molecular formula C10H11NO. It is a substituted aniline derivative with a unique oxetane ring attached to the benzene ring. 4-(3-OXETANYL)BENZENAMINE has potential applications in the field of pharmaceuticals, as well as in the synthesis of various organic compounds. Its structural and functional characteristics make it a valuable building block for the development of new drugs and materials. 4-(3-oxetanyl)benzenamine may also have other industrial uses and could be of interest to researchers and chemists for further exploration and study.
Check Digit Verification of cas no
The CAS Registry Mumber 1221819-62-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,1,8,1 and 9 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1221819-62:
(9*1)+(8*2)+(7*2)+(6*1)+(5*8)+(4*1)+(3*9)+(2*6)+(1*2)=130
130 % 10 = 0
So 1221819-62-0 is a valid CAS Registry Number.
1221819-62-0Relevant articles and documents
PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
-
, (2022/02/24)
Disclosed in the present invention are a pyridazine-3-formamide compound suitable for inhibiting or regulating the Janus kinase (JAK), in particular tyrosine kinase 2 (TYK2), and a preparation method therefor and the medical use thereof. In particular, disclosed in the present invention are a compound as represented by general formula (I) and a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof, a method for treating and/or preventing Janus kinase-mediated related diseases, in particular autoimmune diseases, inflammatory diseases and cancers, by means of using the compound or the pharmaceutically acceptable salt thereof, and a method for preparing the compound or the pharmaceutically acceptable salt thereof. Each substituent of general formula (I) has the same definition as that in the description.